CorMedix Net Income from 2010 to 2026
| CRMD Stock | USD 7.46 0.03 0.40% |
Net Loss | First Reported 2008-12-31 | Previous Quarter 19.8 M | Current Value 108.6 M | Quarterly Volatility 15.1 M |
Check CorMedix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CorMedix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 292.7 K, Interest Expense of 31.1 K or Selling General Administrative of 36.2 M, as well as many indicators such as Price To Sales Ratio of 11.98, Dividend Yield of 0.0179 or PTB Ratio of 5.32. CorMedix financial statements analysis is a perfect complement when working with CorMedix Valuation or Volatility modules.
CorMedix | Net Income | Build AI portfolio with CorMedix Stock |
Analyzing CorMedix's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing CorMedix's current valuation and future prospects.
Latest CorMedix's Net Income Growth Pattern
Below is the plot of the Net Income of CorMedix over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CorMedix financial statement analysis. It represents the amount of money remaining after all of CorMedix operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CorMedix's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CorMedix's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (17.93 M) | 10 Years Trend |
|
Net Income |
| Timeline |
CorMedix Net Income Regression Statistics
| Arithmetic Mean | (20,300,809) | |
| Coefficient Of Variation | (52.69) | |
| Mean Deviation | 8,095,173 | |
| Median | (18,187,529) | |
| Standard Deviation | 10,696,216 | |
| Sample Variance | 114.4T | |
| Range | 42.9M | |
| R-Value | (0.52) | |
| Mean Square Error | 89.3T | |
| R-Squared | 0.27 | |
| Significance | 0.03 | |
| Slope | (1,097,712) | |
| Total Sum of Squares | 1830.5T |
CorMedix Net Income History
Other Fundumenentals of CorMedix
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
CorMedix Net Income component correlations
About CorMedix Financial Statements
CorMedix stakeholders use historical fundamental indicators, such as CorMedix's Net Income, to determine how well the company is positioned to perform in the future. Although CorMedix investors may analyze each financial statement separately, they are all interrelated. For example, changes in CorMedix's assets and liabilities are reflected in the revenues and expenses on CorMedix's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CorMedix. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -16.1 M | -16.9 M | |
| Net Loss | -16.1 M | -16.9 M | |
| Net Loss | -26.7 M | -28.1 M | |
| Net Loss | (0.27) | (0.29) | |
| Net Income Per E B T | 1.07 | 1.10 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CorMedix is a strong investment it is important to analyze CorMedix's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CorMedix's future performance. For an informed investment choice regarding CorMedix Stock, refer to the following important reports:Check out the analysis of CorMedix Correlation against competitors. For information on how to trade CorMedix Stock refer to our How to Trade CorMedix Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Will Pharmaceuticals sector continue expanding? Could CorMedix diversify its offerings? Factors like these will boost the valuation of CorMedix. Projected growth potential of CorMedix fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CorMedix data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 2.21 | Revenue Per Share | Quarterly Revenue Growth 8.102 | Return On Assets | Return On Equity |
CorMedix's market price often diverges from its book value, the accounting figure shown on CorMedix's balance sheet. Smart investors calculate CorMedix's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CorMedix's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CorMedix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CorMedix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CorMedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.